MedPath

Screening for Deep Vein Thrombosis in Intensive Care

Not Applicable
Recruiting
Conditions
Deep Vein Thrombosis
Interventions
Diagnostic Test: Ultrasound screening for lower limbs DVT
Diagnostic Test: Standard-of-care
Registration Number
NCT06246604
Lead Sponsor
University Of Perugia
Brief Summary

Background: venous thromboembolism (VTE) is a common complication in critically ill patients, admitted to the Intensive Care Units (ICUs). At the present time, there is no validated score to estimate risks and benefits of antithrombotic pharmacological prophylaxis in this subset of patients. Results of a pilot study showed that ultrasound (US) screening for deep vein thrombosis (DVT) is associated with a reduced incidence of proximal DVT, up front to an overall increased discovery rate of DVTs. The reduced incidence of proximal DVT could be attributed to an early diagnosis of distal and muscular DVTs, which would eventually receive a more adequate management. Proximal DVTs are associated with a worse long-term prognosis than distal or muscular DVTs, so it can be hypothesized that the active US screening could lead to an improvement of in-hospital and long-term prognosis of patients admitted to the ICU.

Aim of the study: to test whether an active US screening may reduce the incidence of proximal DVT and improve the in-hospital and long-term prognosis of patients admitted to the ICU.

Expected relevance: systematic screening for DVT could improve the management of the pharmacological antithrombotic treatment, leading to a reduction of thromboembolic and bleeding complications. This will eventually lead to an improved in-hospital and long-term prognosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1300
Inclusion Criteria
  • any patient admitted to ICU with a length-of-stay in ICU >96 hours
Exclusion Criteria
  • pregnancy
  • SARS-CoV-2 infection
  • established DVT or pulmonary embolism at admission
  • established coagulation disorder
  • presence of inferior vena cava filter at the admission
  • admission from the ICU of another hospital

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ScreeningUltrasound screening for lower limbs DVTPatients will receive an ultrasound screening for DVT between 48 to 96 hours after the admission to the intensive care. In case of negative ultrasound: * if the pharmacological thromboprophylaxis is NOT possible, ultrasound is repeated after 48-96 hours; * if the pharmacological thromboprophylaxis is possible, re-evaluation is warrant only in case of clinical changes. In case of positive ultrasound: * if the DVT is proximal, it must be treated according to guidelines. Re-evaluation is warranted only in case of clinical changes; * if the DVT is distal and a full or intermediate anti-thrombotic treatment is possible, re-evaluation is warrant only in case of clinical changes; * if the DVT is distal and a full or intermediate anti-thrombotic treatment is NOT possible, the ultrasound is repeated after 48-96 hours.
Standard-of-careStandard-of-careUltrasound examination are performed according to clinical risk of DVT
Primary Outcome Measures
NameTimeMethod
Proximal deep vein thrombosisWithin 48-72 hours after admission to ICU

Deep vein thrombosis located above the popliteal area

Secondary Outcome Measures
NameTimeMethod
Mortality in ICUFrom admission to ICU until the date of death from any cause or transfer to other facility, assessed up to 30 days

Death rate during the hospitalization in ICU

In-hospital mortalityFrom admission to ICU until the date of death from any cause or discharge, assessed up to 30 days

Death rate during the overall hospital stay

90-day mortalityWithin 90 days after the admission of the ICU

Death rate within 90 days after the admission to the ICU

Trial Locations

Locations (4)

Azienda Sanitaria Locale N.1 dell'Umbria

🇮🇹

Gubbio, Italy

Azienda Sanitaria Locale N.2 dell'Umbria

🇮🇹

Foligno, Italy

Azienda Ospedaliera di Perugia

🇮🇹

Perugia, Italy

Azienda Ospedaliera di Terni

🇮🇹

Terni, Italy

© Copyright 2025. All Rights Reserved by MedPath